Clinical Trial Update: CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial update announcing recruitment for CD7 CAR-T cells as a bridge to allogeneic stem cell transplantation in severe aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: Zhejiang University | Conditions: Aplastic Anemia | EARLY_Phase 1 | Status: RECRUITING